Insider Shareholders with Direct Ownership of Halozyme Therapeutics, Inc. (HALO)
This section provides a comprehensive overview of the insiders with direct ownership of Halozyme Therapeutics, Inc. (HALO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
HALOZYME THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Helen Torley
PRESIDENT AND CEO |
1,351,273 | 1,165,051 | 666,744 $31.3 Million | 125 |
Nov 29, 2024
Reduced 1.48%
|
| 26,002 | 51,720 | 183,035 $8.6 Million | 7 |
Nov 29, 2024
Reduced 5.41%
|
|
|
Kenneth J Kelley
Director |
0 | 106,549 | 179,833 $8.44 Million | 8 |
Apr 14, 2021
Reduced 2.71%
|
|
Michael J. La Barre
SVP, CHIEF TECHNICAL OFFICER |
548,821 | 536,849 | 173,756 $8.16 Million | 106 |
Oct 16, 2024
Reduced 5.44%
|
| 26,002 | 79,881 | 69,874 $3.28 Million | 12 |
Aug 14, 2024
Reduced 12.39%
|
|
| 19,501 | 35,000 | 66,815 $3.14 Million | 4 |
May 05, 2023
Added 10.77%
|
|
| 26,002 | 44,498 | 53,611 $2.52 Million | 7 |
Apr 25, 2024
Added 10.81%
|
|
| 26,002 | 5,998 | 46,787 $2.2 Million | 5 |
Apr 25, 2024
Added 12.2%
|
|
| 20,772 | 0 | 20,772 $975,453 | 3 |
Apr 25, 2024
Added 23.84%
|
|
| 19,501 | 30,363 | 20,503 $962,820 | 6 |
Aug 14, 2023
Reduced 32.78%
|
|
|
Masaru Matsuda
SVP, General Counsel |
17,269 | 8,662 | 20,049 $941,501 | 6 |
Sep 04, 2021
Reduced 14.54%
|
| 15,754 | 0 | 15,754 $739,807 | 3 |
Apr 25, 2024
Added 29.21%
|
|
|
Nicole La Brosse
SVP, CHIEF FINANCIAL OFFICER |
65,821 | 55,374 | 15,480 $726,940 | 31 |
Jul 22, 2024
Reduced 6.02%
|
|
Elaine D Sun
SVP, Chief Financial Officer |
22,362 | 8,344 | 14,018 $658,285 | 4 |
Apr 01, 2021
Reduced 22.45%
|
|
Mark Howard Snyder
SVP, CHIEF LEGAL OFFICER |
20,018 | 8,338 | 11,680 $548,492 | 6 |
Feb 16, 2024
Reduced 18.08%
|
| 6,501 | 0 | 6,501 $305,286 | 1 |
Apr 25, 2024
Added 50.0%
|